Welcome to the ValueWiki NOVO NORDISK A S (NVO) article! Register for free or click the "edit" link to contribute!    

NOVO NORDISK A S (NVO)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about NOVO NORDISK A S? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max



Funds w/ NVO: 4
Rank: 348 / 351



Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

11/24/08 12:11 pm Diabetes-Drug Makers Face FDA Hurdle (TheStreet.com)
11/24/08 2:11 am Photo Release -- Merrion Announces License Agreement With Novo Nordisk to Develop Oral Formulation of Insulin Analogues (GlobeNewswire)
11/19/08 8:11 am Big Pharma Steps Up China Investment (at Seeking Alpha)
11/19/08 2:11 am Novo Nordisk: Approval of New Diabetes Drug Is Further Postponed (at Seeking Alpha)
11/18/08 4:11 pm Study puts a total on diabetes cost: $218 billion (AP)
11/18/08 11:11 am Novo Nordisk "Raises" Price On Treating Diabetes (at CNBC)
11/18/08 10:11 am Study Finds Cost of Diabetes in the United States Exceeds $217 Billion (PR Newswire)
11/17/08 5:11 pm Icahn, Byetta Sales Boost Amylin (Update) (at TheStreet.com)
11/17/08 4:11 pm [$$] Recession or Not, We Still Need Drugs (at RealMoney by TheStreet.com)
11/17/08 3:11 pm Amylin Rises on Byetta Sales Data (at TheStreet.com)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

NOVO NORDISK A S Snapshot
NOVO NORDISK A S Leadership
NOVO NORDISK A S Fundamentals
NOVO NORDISK A S Technical Analysis
NOVO NORDISK A S Message Boards

Notes

  1. This is a sample reference.
Personal tools